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Abstract Rab GTPases regulate the membrane transport
pathways by recruiting their specific effector proteins. Melano-
philin, a putative Rab effector, has recently been identified as a
gene that is mutated in leaden mice, in which peripheral
localization of melanosomes is impaired in melanocytes. Genetic
studies suggest that three coat-color mutation genes, dilute
(MyoVad ), ashen (Rab27aash), and leaden (Mlphln), act in the
same or overlapping pathways. Here we have cloned and
characterized a human melanophilin homolog, which belongs to
the rabphilin3/granuphilin-like Rab effector family. Cosedimen-
tation assays using recombinant proteins reveal that melano-
philin directly binds to Rab27a and myosin Va through its
N-terminal and its first C-terminal coiled-coil region, respec-
tively. Moreover, we show that Rab27a, melanophilin, and
myosin Va form a ternary complex in the human melanocyte
cell line HMV-II. These findings suggest that melanophilin has
a role in bridging Rab27a on melanosomes and myosin Va on
actin filaments during melanosome transport. We also propose
that the Rab-binding region conserved in a novel rabphilin3/
granuphilin-like Rab effector family constitutes an K-helix-
based coiled-coil structure. ß 2002 Federation of European
Biochemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
The protein families important for vesicle tra⁄cking have
been characterized and their functions are becoming well de-
¢ned. Rab proteins, which represent the largest family of
small GTPases, are believed to function in regulating the pro-
cesses of vesicle targeting and fusion [1]. Rab proteins cycle
between active (GTP-bound) and inactive (GDP-bound) con-
formation, and exert their function in the active GTP-bound
form by recruiting a variety of downstream e¡ectors.
Rabphilin3, one of the mammalian Rab e¡ector proteins,
directly interacts with the GTP-bound form of Rab3. Associ-
ation with Rab3 requires an amino-terminal region including
a cysteine-rich zinc-¢nger motif [2,3]. In the crystal structure,
the K-helix region just upstream of a zinc-¢nger domain, and
the SGAWFF structural motif, constitute the main interfaces
of rabphilin3 with Rab3a in their complex [4]. Both rabphilin3
and Rab3 are expressed in neurons and neuroendocrine cells
and appear to play a regulatory role in the exocytosis of
synaptic vesicles. However, the phenotype of mice lacking
rabphilin3 is distinct from that of Rab3a-de¢cient mice, and
actually do not exhibit obvious physiological impairments [5].
Therefore, their precise function on the regulated exocytosis
remains unclear.
Recently, we identi¢ed and characterized a novel set of
Rab and its e¡ector, Rab27a/granuphilin, which is localized
on the membrane of insulin granules in pancreatic beta cells
[6,7]. Granuphilin shows homology to rabphilin3 in domain
structure that includes a zinc-¢nger motif at the amino-
terminus and C2 domains at the carboxyl-terminus. Like rab-
philin3, the N-terminal domain of granuphilin speci¢cally
binds to an active GTP-bound form of Rab27a [7]. Although
the molecular mechanisms are unde¢ned, they may function
in regulating exocytosis of insulin-containing secretory gran-
ules.
Another rabphilin3/granuphilin-like protein, melanophilin
encoded by the leaden locus, was recently identi¢ed by posi-
tional cloning [8]. In three independent coat-color mutations,
dilute (MyoVad ), ashen (Rab27aash), and leaden (Mlphln), the
polarized transport of melanosomes is impaired and leads to
abnormal accumulation of melanosomes at the perinuclear
area of the cells rather than at the periphery [9]. Because
the phenotype of all three mutants is rescued by an unidenti-
¢ed gene, dilute suppressor (dsu) [10], myosin Va, Rab27a, and
melanophilin likely function in the same or overlapped mela-
nosome transport pathway. Myosin Va, one of unconvention-
al myosins, is an actin-based and organelle-associated motor
[11]. Melanophilin has a putative Rab-binding sequence at the
N-terminus, which is homologous to those of rabphilin3 and
granuphilin, although its physiological interaction with Rab
protein has not been visualized.
In the present study, we demonstrate that human melano-
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philin indeed binds to Rab27a directly and nucleotide-depen-
dently through its N-terminal region. We further show that
the critical binding region constitutes an K-helix-based coiled-
coil domain, which is commonly seen for other melanophilin-
like proteins found in a cDNA database. In addition, we show
that melanophilin directly binds to myosin Va at one of its
C-terminal coiled-coil domains that are unique to melanophi-
lin. Our ¢ndings regarding the physical interaction of these
three proteins in human melanocytes provide a biochemical
basis for their physiological interactions that are suggested by
previous genetic analyses.
2. Materials and methods
2.1. DNA construction
A full-length human melanophilin cDNA clone (MAMMA1000395,
accession number: AK022207) provided by Helix Research Institute
(Kisarazu, Japan) was ampli¢ed by polymerase chain reaction (PCR)
using primers 5P-GGAATTCATGGGGAAGAAACTGGATCT-3P
and 5P-GGTCGACGAAAGCACAGAGCCAATGAG-3P, and sub-
cloned into the EcoRI and XhoI sites of pcDNA3-HA [12]
(pcDNA3-HA-exph3). Mutagenesis of melanophilin was performed
using the following primers: 5P-CGGGATCCGTGGGTCTCGTT-
CAGATGGGC-3P and 5P-GCGGATCCCATCCGGCCAGAGTCG-
TGAAG-3P for vZinc-¢nger, 5P-GGAATTCATGGGGAAGAAA-
CTGGATCTTTCCAAGCTCACTGATGAAGCGGC-3P for E14A,
5P-CTTGGAAGTTGTTCAAGCAGATT-3P and 5P-TCGGAGGT-
CAAAATCTGCTTGAA-3P for R24A, 5P-TTGACCTCCGAAG-
GAAAGCAGAG-3P and 5P-CTCTAGCCGTTCCTCTGCTTTC-3P
for E32A, 5P-GAAGATCGGCTCACTGGAGTCGTACT-ATG-3P
and 5P-CACATGCTCATAGTACGACTCCAGTGA-3P for W120S,
and 5P-AAGATCGGCTCACTGGAGGCGGCCTATGAG-3P and
5P-TTTCACATGCTCATAGGCCGCCTCCAGTGA-3P for W120A/
Y121A. The PCR products were cloned into restriction enzyme sites
of pcDNA3-HA-exph3. Truncated fragments of melanophilin were
constructed by PCR. The DNA fragment that encodes residues
1106^1580 of mouse myosin Va was ampli¢ed from B16 melanoma
cell cDNAs using primers 5P-GGAATTCCCTAAGCCAGGACA-
CAAGAG-3P and 5P-GAGAGCCAGAAGGAGACAGT-3P. This
fragment coding a melanocyte-medial tail region [13] was ligated
with the DNA fragment that encodes residues 1468^1877 of mouse
myosin Va originally provided by Dr. N.A. Jenkins (National Cancer
Institute, Frederick, MD, USA) [14]. The composite clone that codes
the C-terminal tail region (1106^1877 amino acids) of melanocyte-
form myosin Va was subcloned into pcDNA3.1/HisC (Invitrogen,
Carlsbad, CA, USA) or pGEX4T-1 vector (Amersham Pharmacia
Biotech, Buckinghamshire, UK). The residue numbers of mouse my-
osin Va in this work represent those of the melanocyte-form [13]. All
the subcloned PCR products were directly sequenced. Plasmids bear-
ing Rab27a cDNA were described previously [7].
2.2. Cell culture and transfection
The HMV-II human melanoma cell line, established by T. Kasuga
(Tokyo Medical and Dental Univ.) [15], was provided by the RIKEN
Cell Bank (Tsukuba, Japan). HMV-II cells were grown in Ham’s F-12
medium supplemented with 10% fetal calf serum. Transfections were
performed using FuGENE6 transfection reagent (Roche Diagnostics,
Mannheim, Germany) according to the manufacturer’s instructions.
2.3. Antibodies
Rabbit anti-melanophilin antibodies were raised against glutathione
S-transferase (GST)-fused N-terminal human melanophilin protein
(amino acids 1^301), and speci¢cally recognize human melanophilin
but not mouse melanophilin. Anti-myosin Va antibodies were pro-
duced against GST-fused mouse myosin Va (1468^1877), and specif-
ically recognize both human and mouse myosin Va. Anti-Rab27a and
anti-Rab4 mouse monoclonal antibodies were purchased from BD
Transduction Laboratories (Lexington, KY, USA). Anti-Xpress
mouse and anti-hemagglutinin (HA) rat (clone 3F10) monoclonal
antibodies were purchased from Invitrogen and Roche Diagnostics,
respectively.
2.4. Immunoprecipitation
Cell extracts were prepared in lysis bu¡er containing 20 mM Tris,
pH 7.5, 150 mM NaCl, 2 mM MgCl2, 1 mM EGTA, 1% Triton X-
100, and the following protease inhibitors: 1 mM phenylmethylsul-
fonyl £uoride, 10 Wg/ml of aprotinin, 10 Wg/ml of pepstatin A, and 10
Wg/ml of leupeptin. Immunoprecipitation and immunoblot analyses
were performed as described previously [7]. Brie£y, cell extracts
(3 mg each) were incubated with anti-Rab27a, anti-Rab4, or anti-
Xpress antibodies. Immunoprecipitates and an aliquot of the original
cell extracts (15 Wg) were analyzed by immunoblotting with antibodies
against melanophilin or myosin Va.
2.5. In vitro binding assay with GST fusion proteins
GST fusion proteins were produced as described previously [6]. In
vitro translation of HA- or Xpress-tagged proteins was performed
using the TNT coupled reticulocyte lysate system (Promega, Madison,
WI, USA). Puri¢ed GST-fused proteins (1 Wg) immobilized on 20 Wl
of glutathione-Sepharose beads were incubated with either HMV-II
cell extracts (1 mg total proteins) or various normalized amounts of in
vitro-translated proteins (6^10 Wl) in binding bu¡er (20 mM Tris, pH
7.5, 150 mM NaCl, 2 mM MgCl2, 1 mM EGTA, 0.1% Nonidet P-40,
and the protease inhibitors described above) at 4‡C for 2 h. The beads
were washed three times and the bound proteins were subjected to
SDS^polyacrylamide gel electrophoresis and immunoblotting.
3. Results and discussion
3.1. Rabphilin3/granuphilin-like Rab e¡ectors
We searched for rabphilin3/granuphilin-like proteins in a
cDNA expression database and found three independent
genes, FLJ20163 (accession number: AK000170), MAM-
MA1000395 (AK022207), and KIAA0624 (AB014524). The
predicted proteins of FLJ20163 and MAMMA1000395 were
human homologs of recently reported Slp2-a (synaptotagmin-
like protein 2-a) and melanophilin/Slac2, respectively [16]. In
addition, we found three other genes in a mouse EST data-
base, two of which were identical to Slp-1 and Slp-3. Rabphi-
lin3, granuphilin, and all proteins encoded by those novel
genes have highly conserved amino acid sequences (27^50%)
at their N-termini including the SGAWFF motif that in rab-
philin3 may play a critical role in binding to Rab3a-GTP [4].
Some of them apparently lack tandem C2 domains at their
C-termini. Thus, this novel protein family likely acts as a Rab
e¡ector rather than a Ca2 sensor protein, such as synapto-
tagmin. Because rabphilin3 and granuphilin bind the exocy-
totic Rab proteins, Rab3 and Rab27a, respectively, these pu-
tative Rab e¡ectors may also function in similar exocytotic
pathways. Thus, we termed them exophilins (exocytosis-asso-
ciated rabphilin3/granuphilin-like proteins) (Fig. 1A). Exophi-
lin4/Slp2-a, exophilin5, and exophilin7/Slp1 lack a series of
conserved cysteine residues that form a zinc-¢nger motif, in
their putative Rab-binding regions (Fig. 1A, B), which sug-
gests that this motif is dispensable for Rab binding in some
exophilins. In fact, granuphilin mutant without its zinc-¢nger
region still appears to bind to Rab27a in vivo (S. Torii, un-
published data), although mutation of zinc-coordinating cys-
teine residues in rabphilin3 severely impairs Rab3a binding
[2,3].
3.2. Melanophilin binds to Rab27a through the N-terminal
coiled-coil domain
Among the novel exophilins, a partner of Rab protein is
genetically estimated for melanophilin, since both Rab27a en-
coded by ashen and melanophilin encoded by leaden play
essential roles in the peripheral localization of melanosomes
[8,17], although their interaction has not been de¢ned at a
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molecular level. We therefore biochemically examined whether
melanophilin interacts with Rab27a. First, extracts of the hu-
man melanocyte cell line HMV-II were incubated with bacte-
rially expressed GST-fused Rab27a protein that had been im-
mobilized on glutathione-Sepharose beads and preloaded with
either GDP or GTPQS. Bound melanophilin was then detected
by immunoblotting with anti-melanophilin antibodies. Mela-
nophilin speci¢cally bound to GTPQS-loaded GST^Rab27a,
but not to GDP-bound Rab27a or GST alone (Fig. 2A), in-
dicating that the interaction is regulated in a manner depen-
dent on the nucleotide state of Rab27a.
We next analyzed whether the interaction is direct using
recombinant proteins. GST^Rab27a^GTPQS directly bound
to HA-tagged melanophilin translated in vitro (Fig. 2B).
The region within melanophilin required for binding to
Rab27a was mapped to the N-terminal portion. To analyze
critical amino acids in the N-terminus of melanophilin for
binding to Rab27a, various melanophilin mutants were pro-
duced and directed to in vitro assay. Among these, three me-
lanophilin mutants, vZinc-¢nger (64^107 amino acids-de-
leted), W120S, and W120A/Y121A, bound to GST-fused
Rab27a as similarly as a wild type (Fig. 2C; data not shown).
These results indicate that the tryptophan-based motif in me-
lanophilin is unnecessary for binding to Rab27a, in contrast
to granuphilin (S. Torii, unpublished data). In addition to the
SGAWFF structural element, the N-terminal K-helical region
of rabphilin3 also forms the main interface with Rab3a and
contacts with its switch I and switch II regions in the crystal
structure [4]. This K-helix region of rabphilin3 alone indeed
binds to Rab3a speci¢cally but with low a⁄nity [18]. We in-
troduced three distinct point mutations in the corresponding
region of melanophilin that may a¡ect the charged clusters
separated by hydrophobic amino acids (asterisks in Fig. 1B).
E14A and E32A mutants had no signi¢cant binding activ-
ities to Rab27a, whereas R24A showed a lower activity com-
pared with the wild type (Fig. 2C). These results suggest that
the N-terminal K-helical region of melanophilin is essential for
the binding of Rab27a. It should be noted that the seven
consecutive amino acids deleted in leaden are located in this
region (Fig. 1B, boxed), suggesting that loss of function of
melanophilin in leaden is due to its defect in binding to
Rab27a.
Using the COILS prediction program [19], we found that
this K-helical region of melanophilin may be capable of form-
ing coiled-coils. Analysis of the corresponding regions in other
exophilin members also predicted similar coiled-coil struc-
Fig. 1. Structural comparison of exophilins. A: Schematic representation of primary structures of exophilin proteins. Human melanophilin (exo-
philin3), exophilin4, and exophilin5 are encoded by the human cDNA clones MAMMA1000395, FLJ20163, and KIAA0624, respectively. Exo-
philin8 is estimated by the sequence of a mouse EST clone (BB653357). Gray box, N-terminal homologous Rab-binding region; Zn2, zinc-¢n-
ger motif; dashed box, C2 domain; black box, coiled-coils. B: Alignment of the N-terminal region of exophilins. The putative Rab-binding
coiled-coil sequences of exophilins are shown. Residues conserved in at least ¢ve members are shown in dark boxes. Asterisks indicate the posi-
tions of the amino acids mutated in this study. Amino acids in human melanophilin in a box correspond to those of mouse melanophilin that
are deleted in leaden.
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tures, though with di¡erent probabilities (data not shown).
We suggest that these exophilin-speci¢c coiled-coil sequences
based by K-helices may be involved in their binding to Rab
proteins.
3.3. Melanophilin binds to myosin Va through the C-terminal
coiled-coil domain
Myosin Va encoded by dilute is also genetically shown to be
essential for the transport of melanosomes [14]. Furthermore,
Rab27a and myosin Va are colocalized on melanosomes and
form a complex in melanocytes [20^23]. Using a similar cose-
dimentation assay described above, we showed that melano-
philin speci¢cally bound to the GST-fused carboxyl-terminal
tail region of myosin Va (1106^1877), but not to GST alone,
in HMV-II cell extracts (Fig. 2D). The interaction is direct
and speci¢c because GST^myosin Va bound to HA-tagged
melanophilin translated in vitro (Fig. 2B, E), but not to
Xpress-tagged Rab27a similarly produced (data not shown).
Furthermore, in vitro-translated myosin Va-tail protein was
coprecipitated with GST-fused melanophilin, but not with
GTPQS-loaded GST^Rab27a (Fig. 2F). These ¢ndings indi-
cate that melanophilin directly mediates the interaction be-
tween Rab27a and myosin Va.
The region within melanophilin required for binding to my-
osin Va was mapped to the C-terminal portion (Fig. 2B).
Unlike rabphilin3 and granuphilin, the C-terminal region of
melanophilin lacks C2 domains, but instead possesses two
tandem coiled-coils at the residues 345^381 (Coil1) and 429^
468 (Coil2) (Fig. 1A). We constructed melanophilin fragments
to determine whether these coiled-coil structures are involved
in the binding to myosin Va. As shown in Fig. 2E, the ¢rst
coiled-coil region (Coil1) was capable of and su⁄cient for
binding to GST-fused myosin Va, indicating that the Coil1
region constitutes the speci¢c binding domain.
Fig. 2. In vitro binding assays among melanophilin, Rab27a, and myosin Va. A: Aliquots of glutathione beads containing either GST alone or
GST-fused Rab27a preloaded with GDP or GTPQS were incubated with HMV-II cell extracts and then washed three times. Proteins that
bound to the GST fusion proteins were analyzed by immunoblotting with anti-melanophilin antibodies (upper panel). Total GST protein levels
were visualized by Coomassie blue staining (lower panel). B: GTPQS-loaded GST^Rab27a or GST-fused myosin Va C-terminal fragment
(1106^1877 amino acids) were incubated with in vitro-translated, HA-tagged N-terminal fragment (1^301) or C-terminal fragment (264^572)
of melanophilin. Bound proteins as well as 10% of input proteins (bottom panel) were analyzed by immunoblotting with anti-HA antibodies.
C: GTPQS-loaded GST^Rab27a was incubated with in vitro-translated, HA-tagged wild-type melanophilin, zinc-¢nger-deleted melanophilin
(vZinc-¢nger), or melanophilin point mutants (E14A, R24A, E32A, or W120A/Y121A). Bound proteins (upper panel) as well as 10% of input
proteins (lower panel) were analyzed as in (B). D: GST alone or GST-fused myosin Va C-terminal fragment were incubated with HMV-II cell
extracts, and then bound melanophilin was detected by immunoblotting as in A (upper panel). Total GST protein levels were visualized (lower
panel). E: GST^myosin Va was incubated with in vitro-translated, HA-tagged fragments of melanophilin; Coil1 (264^411), Coil2 (388^490),
Coil1+2 (336^490), or C-term. (264^572). Bound proteins (upper panel) as well as 10% of input proteins (lower panel) were analyzed as in (B).
F: GST^melanophilin (264^572) or GTPQS-loaded GST^Rab27a were incubated with in vitro-translated, Xpress-tagged myosin Va (1106^1877).
Proteins that bound to the GST fusion proteins were analyzed by immunoblotting with anti-Xpress antibodies (upper panel). Total GST pro-
tein levels were visualized (lower panel).
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3.4. Rab27a, melanophilin, and myosin Va interact together in
melanocytes
To explore whether these interactions exist in melanocytes
under physiologic conditions, coimmunoprecipitation experi-
ments were performed within lysates from HMV-II cells.
Rab27a immunoprecipitates contained a signi¢cant amount
of myosin Va and melanophilin, whereas those of Rab4 did
not (Fig. 3A). These ¢ndings indicate that the ternary com-
plex consisting of Rab27a, melanophilin, and myosin Va
forms in melanocytes, which is consistent with a previous
report showing the existence of the Rab27a^myosin Va com-
plex in melanocytes [21]. Furthermore, our immuno£uores-
cence analysis suggests that these three proteins partially
colocalize with melanosomes (data not shown). These obser-
vations combined with the previous ¢ndings suggest that me-
lanophilin associates on melanosomes presumably through a
direct interaction with Rab27a, which in turn directly recruits
the actin-based motor protein myosin Va. It is notable that
granuphilin, another Rab27a e¡ector in the pancreatic beta
cell, was not expressed in the melanocyte cell lines tested [7].
Finally, we de¢ned the interaction domain of myosin Va
against melanophilin using a coimmunoprecipitation analysis.
Previous studies suggest that the C-terminal tail domain
(1258^1877) is involved in the association with melanosomes
[20]. Xpress-tagged C-terminal truncation constructs of myo-
sin Va were transfected into HMV-II cells, and the cell ex-
tracts were then immunoprecipitated with anti-Xpress anti-
bodies. Myosin Va-tail consists of amino acids 1106^1877
(melanocyte-medial and globular tails) coprecipitated melano-
philin, whereas the globular tail alone (1468^1877) failed to
bind melanophilin (Fig. 3B). Tissue-speci¢c alternative splic-
ing within the exons B^F (amino acid; 1284^1435) of myosin
Va gene generates a brain-speci¢c form, a melanocyte-speci¢c
form, and other forms [13]. The brain form does not localize
on melanosomes when expressed in melanocytes [24], suggest-
ing that variable regions from melanocyte-speci¢c exon D
(1318^1334) and/or exon F (1411^1435) are important for
myosin Va association with melanosomes. Taken together,
the binding activity of myosin Va to melanophilin highly cor-
relates with its speci¢c localization on melanosomes.
In summary, the present study showed the structural fea-
tures of the rabphilin3/granuphilin-like Rab e¡ector proteins,
termed exophilins. They have a highly conserved N-terminal
domain that is capable of forming coiled-coils to directly bind
to Rabs. We ¢rst characterized melanophilin, which is defec-
tive in leaden, and demonstrated that it directly binds to both
Rab27a and myosin Va. Further characterization of other
exophilins and identi¢cation of their Rab partners will help
identify their function on related secretory pathways.
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